Brief: Sandoz Group Reports Q1 Sales Of $2.48 Bln, Confirms Guidance

Sandoz AG

30/04/2025 06:07

April 30 (Reuters) - SANDOZ GROUP AG SDZ.S:

SANDOZ Q1 SALES USD 2,480 MILLION

REPORTS Q1 2025 NET SALES IN LINE WITH COMPANY EXPECTATIONS; FULL-YEAR GUIDANCE CONFIRMED

FULL-YEAR 2025 GUIDANCE CONFIRMED: MID SINGLE-DIGIT NET-SALES GROWTH AND CORE EBITDA MARGIN OF AROUND 21%

FULL-YEAR IMPACT OF US GOVERNMENT'S CONFIRMED RECENT TARIFFS WITHIN GUIDANCE

US FIRST-QUARTER NET SALES REPRESENTED LESS THAN ONE-FIFTH OF TOTAL NET Q1 SALES

DECIDED TO MINIMIZE ONGOING PHASE III TRIAL IN PATIENTS WITH UNTREATED METASTATIC NON-SQUAMOUS NON-SMALL CELL LUNG CANCER FOR PROPOSED BIOSIMILAR, PEMBROLIZUMAB

COMPANY IS ASSESSING IMPLICATIONS, INCLUDING FOR ITS WIDER BIOSIMILARS PIPELINE

Source text: ID:nGNE8CrJkn

Further company coverage: SDZ.S

 (Gdansk Newsroom)

 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))